REG - Alkemy Capital Invs. - Initiation of Research Coverage by VSA Capital

Alkemy Capital InvestmentsAnnouncement

20/06/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220620:nRST3868Pa&default-theme=true

RNS Number : 3868P  Alkemy Capital Investments PLC  20 June 2022

 

20 June 2022

 

Alkemy Capital Investments Plc

 

 

Initiation of Research Coverage by VSA Capital

 

Alkemy Capital Investments plc ("Alkemy"), is pleased to announce that
international investment banking and broking firm, VSA Capital ("VSA"), has
initiated coverage on the Company. The research follows a recent site visit by
VSA to the world-class Wilton International Chemicals Park and the Teesside
Port facilities, where Alkemy, through its wholly-owned subsidiary Tees Valley
Lithium Ltd ("TVL"), has secured a 9.6ha brownfields site to develop,
construct and operate the world's leading independent and sustainable lithium
hydroxide production facility.

The initiation note is available to view here
www.alkemycapital.co.uk/investors/analyst-coverage
(http://www.alkemycapital.co.uk/investors/analyst-coverage)

Further information

For further information, please visit the Company's website:
www.alkemycapital.co.uk (http://www.alkemycapital.co.uk) or
www.teesvalleylithium.co.uk (http://www.teesvalleylithium.co.uk)

-Ends-

 Alkemy Capital Investments Plc    Tel: 0207 317 0636


 Sam Quinn                         info@alkemycapital.co.uk (mailto:info@alkemycapital.co.uk)

 VSA Capital Limited               Tel: 0203 005 5000

 Andrew Monk (Corporate Broking)

 Andrew Raca (Corporate Finance)
 Shard Capital Partners LLP

 Damon Heath                       Tel: 0207 186 9952

                                   damon.heath@shardcapital.com (mailto:damon.heath@shardcapital.com)

 Isabella Pierre                   Tel: 0207 186 9927

                                   isabella.pierre@shardcapital.com (mailto:isabella.pierre@shardcapital.com)

 

 

NOTES TO EDITORS

Alkemy is seeking to develop, construct and operate the world's leading
independent and sustainable lithium hydroxide production facility.

Alkemy, through its wholly-owned subsidiary Tees Valley Lithium, has secured a
9.6ha brownfields site at the Wilton International Chemicals Park located in
Teesside, a major UK Freeport.

Alkemy has completed a Class 4 Feasibility Study for its proposed lithium
hydroxide facility which will process feedstock imported from various sources
to produce 96,000 tonnes of a premium, low-carbon lithium hydroxide annually,
representing around 15% of Europe's projected demand.

 

 

Forward Looking Statements

This news release contains forward‐looking information. The statements are
based on reasonable assumptions and expectations of management and Alkemy
provides no assurance that actual events will meet management's expectations.
In certain cases, forward‐looking information may be identified by such
terms as "anticipates", "believes", "could", "estimates", "expects", "may",
"shall", "will", or "would". Although Alkemy believes the expectations
expressed in such forward‐looking statements are based on reasonable
assumptions, such statements are not guarantees of future performance and
actual results or developments may differ materially from those projected.
Mining exploration and development is an inherently risky business. In
addition, factors that could cause actual events to differ materially from the
forward-looking information stated herein include any factors which affect
decisions to pursue mineral exploration on the relevant property and the
ultimate exercise of option rights, which may include changes in market
conditions, changes in metal prices, general economic and political
conditions, environmental risks, and community and non-governmental actions.
Such factors will also affect whether Alkemy will ultimately receive the
benefits anticipated pursuant to relevant agreements. This list is not
exhaustive of the factors that may affect any of the forward‐looking
statements. These and other factors should be considered carefully and readers
should not place undue reliance on forward-looking information.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  UPDBIGDLSUBDGDC